Literature DB >> 27330075

A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts.

David L Masica1,2,3, Marco Dal Molin1,4,3, Christopher L Wolfgang5,6,3, Tyler Tomita2, Mohammad R Ostovaneh7, Amanda Blackford8, Robert A Moran7, Joanna K Law7, Thomas Barkley4, Michael Goggins7,6,3, Marcia Irene Canto7, Meredith Pittman4,3, James R Eshleman3,9, Syed Z Ali4, Elliot K Fishman10, Ihab R Kamel10, Siva P Raman10, Atif Zaheer10, Nita Ahuja5, Martin A Makary5, Matthew J Weiss5, Kenzo Hirose5, John L Cameron5, Neda Rezaee5, Jin He5, Young Joon Ahn5, Wenchuan Wu5, Yuxuan Wang3,9, Simeon Springer3,9, Luis L Diaz5,3,9, Nickolas Papadopoulos3,9, Ralph H Hruban4,6,3,9, Kenneth W Kinzler3,9, Bert Vogelstein3,9, Rachel Karchin11,2,6,3, Anne Marie Lennon11,5,7,3.   

Abstract

OBJECTIVE: Our objective was to develop an approach for selecting combinatorial markers of pathology from diverse clinical data types. We demonstrate this approach on the problem of pancreatic cyst classification.
MATERIALS AND METHODS: We analyzed 1026 patients with surgically resected pancreatic cysts, comprising 584 intraductal papillary mucinous neoplasms, 332 serous cystadenomas, 78 mucinous cystic neoplasms, and 42 solid-pseudopapillary neoplasms. To derive optimal markers for cyst classification from the preoperative clinical and radiological data, we developed a statistical approach for combining any number of categorical, dichotomous, or continuous-valued clinical parameters into individual predictors of pathology. The approach is unbiased and statistically rigorous. Millions of feature combinations were tested using 10-fold cross-validation, and the most informative features were validated in an independent cohort of 130 patients with surgically resected pancreatic cysts.
RESULTS: We identified combinatorial clinical markers that classified serous cystadenomas with 95% sensitivity and 83% specificity; solid-pseudopapillary neoplasms with 89% sensitivity and 86% specificity; mucinous cystic neoplasms with 91% sensitivity and 83% specificity; and intraductal papillary mucinous neoplasms with 94% sensitivity and 90% specificity. No individual features were as accurate as the combination markers. We further validated these combinatorial markers on an independent cohort of 130 pancreatic cysts, and achieved high and well-balanced accuracies. Overall sensitivity and specificity for identifying patients requiring surgical resection was 84% and 81%, respectively.
CONCLUSIONS: Our approach identified combinatorial markers for pancreatic cyst classification that had improved performance relative to the individual features they comprise. In principle, this approach can be applied to any clinical dataset comprising dichotomous, categorical, and continuous-valued parameters.
© The Author 2016. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  IPMN; MOCA; clinical model; combination marker; composite marker; mucinous cyst; pancreatic cyst

Mesh:

Substances:

Year:  2016        PMID: 27330075      PMCID: PMC5201184          DOI: 10.1093/jamia/ocw069

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   4.497


  19 in total

1.  Beyond single-marker analyses: mining whole genome scans for insights into treatment responses in severe sepsis.

Authors:  M Man; S L Close; A D Shaw; G R Bernard; I S Douglas; R J Kaner; D Payen; J-L Vincent; S Fossceco; J M Janes; A G Leishman; L O'Brien; M D Williams; J G N Garcia
Journal:  Pharmacogenomics J       Date:  2012-02-07       Impact factor: 3.550

2.  Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.

Authors:  Jian Wu; Yuchen Jiao; Marco Dal Molin; Anirban Maitra; Roeland F de Wilde; Laura D Wood; James R Eshleman; Michael G Goggins; Christopher L Wolfgang; Marcia I Canto; Richard D Schulick; Barish H Edil; Michael A Choti; Volkan Adsay; David S Klimstra; G Johan A Offerhaus; Alison P Klein; Levy Kopelovich; Hannah Carter; Rachel Karchin; Peter J Allen; C Max Schmidt; Yoshiki Naito; Luis A Diaz; Kenneth W Kinzler; Nickolas Papadopoulos; Ralph H Hruban; Bert Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-08       Impact factor: 11.205

3.  Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival.

Authors:  David L Masica; Rachel Karchin
Journal:  Cancer Res       Date:  2011-05-09       Impact factor: 12.701

4.  Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.

Authors:  Jian Wu; Hanno Matthaei; Anirban Maitra; Marco Dal Molin; Laura D Wood; James R Eshleman; Michael Goggins; Marcia I Canto; Richard D Schulick; Barish H Edil; Christopher L Wolfgang; Alison P Klein; Luis A Diaz; Peter J Allen; C Max Schmidt; Kenneth W Kinzler; Nickolas Papadopoulos; Ralph H Hruban; Bert Vogelstein
Journal:  Sci Transl Med       Date:  2011-07-20       Impact factor: 17.956

5.  Role of a multidisciplinary clinic in the management of patients with pancreatic cysts: a single-center cohort study.

Authors:  Anne Marie Lennon; Lindsey L Manos; Ralph H Hruban; Syed Z Ali; Elliot K Fishman; Ihab R Kamel; Siva P Raman; Atif Zaheer; Susan Hutfless; Ashley Salamone; Vandhana Kiswani; Nita Ahuja; Martin A Makary; Matthew J Weiss; Kenzo Hirose; Michael Goggins; Christopher L Wolfgang
Journal:  Ann Surg Oncol       Date:  2014-05-08       Impact factor: 5.344

6.  A combination of molecular markers and clinical features improve the classification of pancreatic cysts.

Authors:  Simeon Springer; Yuxuan Wang; Marco Dal Molin; David L Masica; Yuchen Jiao; Isaac Kinde; Amanda Blackford; Siva P Raman; Christopher L Wolfgang; Tyler Tomita; Noushin Niknafs; Christopher Douville; Janine Ptak; Lisa Dobbyn; Peter J Allen; David S Klimstra; Mark A Schattner; C Max Schmidt; Michele Yip-Schneider; Oscar W Cummings; Randall E Brand; Herbert J Zeh; Aatur D Singhi; Aldo Scarpa; Roberto Salvia; Giuseppe Malleo; Giuseppe Zamboni; Massimo Falconi; Jin-Young Jang; Sun-Whe Kim; Wooil Kwon; Seung-Mo Hong; Ki-Byung Song; Song Cheol Kim; Niall Swan; Jean Murphy; Justin Geoghegan; William Brugge; Carlos Fernandez-Del Castillo; Mari Mino-Kenudson; Richard Schulick; Barish H Edil; Volkan Adsay; Jorge Paulino; Jeanin van Hooft; Shinichi Yachida; Satoshi Nara; Nobuyoshi Hiraoka; Kenji Yamao; Susuma Hijioka; Schalk van der Merwe; Michael Goggins; Marcia Irene Canto; Nita Ahuja; Kenzo Hirose; Martin Makary; Matthew J Weiss; John Cameron; Meredith Pittman; James R Eshleman; Luis A Diaz; Nickolas Papadopoulos; Kenneth W Kinzler; Rachel Karchin; Ralph H Hruban; Bert Vogelstein; Anne Marie Lennon
Journal:  Gastroenterology       Date:  2015-08-04       Impact factor: 22.682

7.  Collections of simultaneously altered genes as biomarkers of cancer cell drug response.

Authors:  David L Masica; Rachel Karchin
Journal:  Cancer Res       Date:  2013-01-21       Impact factor: 12.701

8.  Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis.

Authors:  Ling Li; David Masica; Masaharu Ishida; Ciprian Tomuleasa; Sho Umegaki; Anthony N Kalloo; Christos Georgiades; Vikesh K Singh; Mouen Khashab; Stuart Amateau; Zhiping Li; Patrick Okolo; Anne-Marie Lennon; Payal Saxena; Jean-Francois Geschwind; Todd Schlachter; Kelvin Hong; Timothy M Pawlik; Marcia Canto; Joanna Law; Reem Sharaiha; Clifford R Weiss; Paul Thuluvath; Michael Goggins; Eun Ji Shin; Haoran Peng; Vivek Kumbhari; Susan Hutfless; Liya Zhou; Esteban Mezey; Stephen J Meltzer; Rachel Karchin; Florin M Selaru
Journal:  Hepatology       Date:  2014-07-25       Impact factor: 17.425

9.  Resected serous cystic neoplasms of the pancreas: a review of 158 patients with recommendations for treatment.

Authors:  Charles Galanis; Amir Zamani; John L Cameron; Kurtis A Campbell; Keith D Lillemoe; David Caparrelli; David Chang; Ralph H Hruban; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

10.  The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection.

Authors:  Pamela Valva; Paola Casciato; Juan M Diaz Carrasco; Adrian Gadano; Omar Galdame; María Cristina Galoppo; Eduardo Mullen; Elena De Matteo; María Victoria Preciado
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

View more
  14 in total

1.  Predicting the Grade of Dysplasia of Pancreatic Cystic Neoplasms Using Cyst Fluid DNA Methylation Markers.

Authors:  Tatsuo Hata; Marco Dal Molin; Seung-Mo Hong; Koji Tamura; Masaya Suenaga; Jun Yu; Hiraku Sedogawa; Matthew J Weiss; Christopher L Wolfgang; Anne Marie Lennon; Ralph H Hruban; Michael G Goggins
Journal:  Clin Cancer Res       Date:  2017-02-01       Impact factor: 12.531

2.  Simple Detection of Telomere Fusions in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Cyst Fluid.

Authors:  Tatsuo Hata; Marco Dal Molin; Anne McGregor-Das; Tae Jun Song; Christopher Wolfgang; James R Eshleman; Ralph H Hruban; Michael Goggins
Journal:  J Mol Diagn       Date:  2017-12-08       Impact factor: 5.568

Review 3.  [Cystic pancreatic tumors: diagnostics and new biomarkers].

Authors:  A W Berger; T Seufferlein; A Kleger
Journal:  Chirurg       Date:  2017-11       Impact factor: 0.955

4.  Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential.

Authors:  Ajay V Maker; Vincent Hu; Shrihari S Kadkol; Lenny Hong; William Brugge; Jordan Winter; Charles J Yeo; Thilo Hackert; Markus Büchler; Rita T Lawlor; Roberto Salvia; Aldo Scarpa; Claudio Bassi; Stefan Green
Journal:  J Am Coll Surg       Date:  2019-02-19       Impact factor: 6.113

5.  Is the Early Detection of Pancreatic Cancer Possible? It Is Good News, Bad News.

Authors:  Ralph H Hruban
Journal:  Pancreas       Date:  2019 May/Jun       Impact factor: 3.327

6.  A multimodality test to guide the management of patients with a pancreatic cyst.

Authors:  Simeon Springer; David L Masica; Marco Dal Molin; Christopher Douville; Christopher J Thoburn; Bahman Afsari; Lu Li; Joshua D Cohen; Elizabeth Thompson; Peter J Allen; David S Klimstra; Mark A Schattner; C Max Schmidt; Michele Yip-Schneider; Rachel E Simpson; Carlos Fernandez-Del Castillo; Mari Mino-Kenudson; William Brugge; Randall E Brand; Aatur D Singhi; Aldo Scarpa; Rita Lawlor; Roberto Salvia; Giuseppe Zamboni; Seung-Mo Hong; Dae Wook Hwang; Jin-Young Jang; Wooil Kwon; Niall Swan; Justin Geoghegan; Massimo Falconi; Stefano Crippa; Claudio Doglioni; Jorge Paulino; Richard D Schulick; Barish H Edil; Walter Park; Shinichi Yachida; Susumu Hijioka; Jeanin van Hooft; Jin He; Matthew J Weiss; Richard Burkhart; Martin Makary; Marcia I Canto; Michael G Goggins; Janine Ptak; Lisa Dobbyn; Joy Schaefer; Natalie Sillman; Maria Popoli; Alison P Klein; Cristian Tomasetti; Rachel Karchin; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Christopher L Wolfgang; Ralph H Hruban; Anne Marie Lennon
Journal:  Sci Transl Med       Date:  2019-07-17       Impact factor: 17.956

7.  Machine learning principles applied to CT radiomics to predict mucinous pancreatic cysts.

Authors:  Adam M Awe; Michael M Vanden Heuvel; Tianyuan Yuan; Victoria R Rendell; Mingren Shen; Agrima Kampani; Shanchao Liang; Dane D Morgan; Emily R Winslow; Meghan G Lubner
Journal:  Abdom Radiol (NY)       Date:  2021-10-12

Review 8.  Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Kiara A Tulla; Ajay V Maker
Journal:  Langenbecks Arch Surg       Date:  2017-12-07       Impact factor: 3.445

Review 9.  ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts.

Authors:  Grace H Elta; Brintha K Enestvedt; Bryan G Sauer; Anne Marie Lennon
Journal:  Am J Gastroenterol       Date:  2018-02-27       Impact factor: 10.864

10.  European evidence-based guidelines on pancreatic cystic neoplasms.

Authors: 
Journal:  Gut       Date:  2018-03-24       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.